Methyl Aminolevulinate 16%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Methyl Aminolevulinate 16%, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment [NA]